Figure 2
Down-regulation of resistin by LPS in adipose tissues. (1) In vivo effects. Expression of resistin mRNA (A) and protein (B) in lean mice treated with LPS (80 μg/kg body weight per day) for
7 days. Resistin mRNA (C) and protein (D) in db/db mice treated with LPS (100 μg/kg body weight per day) for 7 days. Resistin mRNA levels are normalized to β-actin mRNA levels,
and the results are mean±s.e.m. of three independent experiments and analyzed by one-way ANOVA. *P<0.05, **P<0.01 compared with PBS group, n=6. (2) Effects in cultured adipocytes and ex vivo adipose tissues. Time-dependent response to 1000 ng/ml LPS in primary adipocytes (E), 3T3-L1 adipocytes (I) and adipose tissue
fragments (L). Dose-dependent response to LPS treatment for 24 h in primary adipocytes (F), 3T3-L1 adipocytes (J) and adipose
tissue fragments (M). Reversible effect of LPS on resistin expression. Adipocytes (G) and adipose tissues (N) were treated
with LPS (300 ng/ml) for 8, 24, or 8 h then withdrawal of LPS for 16 h. Effect on resistin protein levels in primary rat adipocytes
(H) and 3T3-L1 cells (K) treated with 1000 ng/ml LPS for 24 h. Resistin mRNA levels are normalized to β-actin mRNA levels,
and the results are mean±s.e.m. of three independent experiments and analyzed by one-way ANOVA. *P<0.05, **P<0.01 compared with PBS group; #P<0.05, ##P<0.01 compared with LPS (300 ng/ml) treatment for 24 h, 8 h groups; n=6.